The investment from Constellation Brands that is rocking the marijuana stocks news circuit today comes in at a total of $4 billion. This investment will have the company buying a total of 104.5 million shares of CGC stock directly from the company.
The decision to purchase the shares of CGC stock will give Constellation Brands a 38% stake in the company, in combination with its previous ownership. STZ will be acquiring each of the new shares for C$48.60. This represents a roughly 51% premium to the stock’s closing price on Aug. 14, 2018.
Canopy Growth says that the investment will immediately give it $4 billion in funds to work with. The company says that it plans to use this money to grow its business in emerging recreational cannabis markets.
Canopy Growth’s focus on new markets means that the funds won’t go toward its Canadian business, which is already mature. Instead, the company notes that the funds will be used to grow its business in 30 other countries. The U.S. is one of the countries that CGC will focus on.
“Through this investment, we are selecting Canopy Growth as our exclusive global cannabis partner,” Rob Sands, CEO of Constellation Brands, said in a statement. “Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market- leading capabilities in this space. We look forward to supporting Canopy as they extend their recognized global leadership position in the medical and recreational cannabis space.”
CGC stock was up 29% and STZ stock was down 7% as of noon Wednesday.
As of this writing, William White did not hold a position in any of the aforementioned securities.